Web-Based Survey of Pain, Stress and Complementary and Alternative Medicine

NCT00740233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2300

Last updated 2014-03-27

No results posted yet for this study

Summary

The investigators are inviting people with fibromyalgia, IBS, interstitial cystitis, chronic pain, and other chronic and recurring conditions to sign up and participate in a year-long Internet-based survey to study the effectiveness of alternative medicine and the interactions among stress and coping, pain, and treatment outcomes.

The survey is called PROCAIM, which stands for Patient-Reported Outcomes from Complementary, Alternative, and Integrative Medicine. PROCAIM was developed under a grant to UCLA researchers from the National Center for Complementary and Alternative Medicine.

This is a web-based study composed of surveys that will recur at intervals over 1 year!

TO ENROLL

* Log in to our web site: http://www.procaim.org/
* Register as a New User.
* Select clinic name: ClinicalTrials.gov.
* Read and sign the Consent Form.

After participants"sign" the form with their email address, participants can begin to answer the first in a series of questionnaires. The system will send participants email reminders at the time of each scheduled follow-up for one year.

For further information about PROCAIM, please contact:

* Deborah Ackerman, Ph.D.
* Department of Epidemiology
* UCLA School of Public Health
* Box 951772
* Los Angeles, CA 90095-1772
* [email protected]

Conditions

Sponsors & Collaborators

Principal Investigators

  • Deborah Ackerman, Ph.D. · UCLA School of Public Health

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-10-31
Completion
2010-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00740233 on ClinicalTrials.gov